Percentage of children newly prescribed attention-deficit/hyperactivity disorder (ADHD) medication who had at least three follow-up care visits within a 10-month period, one of which is within 30 days of when the first ADHD medication was dispensed.
An Initiation Phase Rate and Continuation and Maintenance Phase Rate are reported.
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.20 Testing Data Sources
-
1.14 Numerator
Among children newly prescribed ADHD medication, those who had timely and continuous follow-up visits.
-
1.15 Denominator
Children 6-12 years of age newly prescribed ADHD medication.
-
Exclusions
Children who had an acute inpatient encounter for mental health or chemical dependency following the Index Prescription Start Date
Children with a diagnosis of narcolepsy: Many of the medications used to identify patients for the denominator of this measure are also used to treat narcolepsy. Children with narcolepsy who are pulled into the denominator are then removed by the narcolepsy exclusion.
Children using hospice services during the measurement year. Children in hospice may not be able to receive the necessary follow-up care.
-
OLD 1.12 MAT output not attachedAttached
-
Most Recent Endorsement ActivityEndorsed Behavioral Health and Substance Use Spring Cycle 2020Initial EndorsementLast Updated
-
Steward Organization EmailSteward Organization Copyright
© 2020 by the National Committee for Quality Assurance
1100 13th Street, NW, 3rd floor
Washington, DC 20005
-
-
-
Risk AdjustmentRisk adjustment approachOffRisk adjustment approachOffConceptual model for risk adjustmentOffConceptual model for risk adjustmentOff
-